Buket Altınok Güneş

Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells

Tülin Özkan, Yalda Hekmatshoar, Arzu Zeynep Karabay et al. · Leukemia Research · 2021 · 26 citations

Oncology, Medicine, Antimicrobial Chemotherapy +9

Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms

Yalda Hekmatshoar, Tülin Özkan, Buket Altınok Güneş et al. · Cellular and Molecular Biology · 2018 · 22 citations · Full text

Molecular Biology, Cell Cycle, Cellular Physiology +19

Expression analysis of Akirin-2, NFκB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia

Arzu Zeynep Karabay, Tülin Özkan, Yalda Hekmatshoar et al. · Hematology · 2018 · 16 citations · Full text

Palladium Metal Nanocomposites Based on PEI-Functionalized Nitrogen-Doped Graphene Quantum Dots: Synthesis, Characterization, Density Functional Theory Modeling, and Cell Cycle Arrest Effects on Human Ovarian Cancer Cells

Buket Altınok Güneş, Omer Faruk Kırlangıç, Asuman Sunguroğlu et al. · ACS Omega · 2024 · 15 citations · Full text

Genetic Polymorphisms in <i>PRM1</i> , <i>PRM2</i> , and <i>YBX2</i> Genes are Associated with Male Factor Infertility

Sena Aydos, Yalda Hekmatshoar, Buket Altınok Güneş et al. · Genetic Testing and Molecular Biomarkers · 2017 · 12 citations